Reply to A. Braillon
- PMID: 28398849
- DOI: 10.1200/JCO.2017.73.0135
Reply to A. Braillon
Comment on
-
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.J Clin Oncol. 2017 Mar;35(7):734-742. doi: 10.1200/JCO.2016.68.2153. Epub 2017 Jan 9. J Clin Oncol. 2017. PMID: 28068175
-
Recurrence in Early-Stage Hepatocellular Carcinoma: CpG Methylation and Smoking.J Clin Oncol. 2017 Jun 20;35(18):2097-2098. doi: 10.1200/JCO.2017.72.3932. Epub 2017 Apr 11. J Clin Oncol. 2017. PMID: 28398848 No abstract available.